Developing new therapeutic options for diabetic retinopathy

Published on May 8, 2026
Queen’s University Belfast researchers hope to develop a next-generation therapy that could help patients who do not respond to existing treatments
Continue reading on website
Other news

Warby Parker Sees Growth in First Quarter, Reaffirms Full-Year Guidance

May 8, 2026
NEW YORK—Warby Parker Inc. (NYSE: WRBY) has announced financial results for the first quarter ended March 31, 2026, reporting $242.4 million in revenue, a year-over-year increase of $18.7 million, or 8.3 percent. The company also reported that the first quarter generated net income of $3.2 million, with adjusted EBITDA rising to $29.6 million, exceeding the company’s guidance. Active customers inc

Research explores temporary effects of low-dose atropine in young adults

May 11, 2026
A US study has found that a single drop of low-dose atropine causes changes in pupil size and focusing ability that persist for 24 hours